Profile data is unavailable for this security.
About the company
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
- Revenue in USD (TTM)174.02bn
- Net income in USD6.42bn
- Incorporated2001
- Employees104.90k
- LocationElevance Health Inc220 Virginia AvenueINDIANAPOLIS 46204United StatesUSA
- Phone+1 (317) 488-6000
- Websitehttps://www.elevancehealth.com/
Mergers & acquisitions
| Acquired company | ELV:NYQ since announced | Transaction value |
|---|---|---|
| RSV QOZB LTSS Inc | -18.79% | -- |
| Indiana University Health Inc-Insurance Business | -25.76% | -- |
| Paragon Healthcare Inc | -16.00% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp Holdings Inc | 12.71bn | 435.50m | 20.09bn | 67.00k | 46.54 | 2.46 | 19.02 | 1.58 | 5.16 | 5.16 | 150.40 | 97.61 | 0.7162 | 19.41 | 5.93 | 189,743.30 | 2.46 | 6.27 | 3.00 | 7.37 | 27.92 | 32.33 | 3.44 | 9.51 | 1.30 | 5.59 | 0.455 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Natera Inc | 1.53bn | -214.69m | 20.95bn | 3.28k | -- | 23.93 | -- | 13.67 | -1.77 | -1.77 | 12.59 | 7.08 | 1.01 | 14.29 | 5.45 | 466,774.80 | -14.14 | -36.17 | -17.55 | -46.60 | 57.66 | 45.88 | -14.01 | -56.15 | 4.23 | -- | 0.2947 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
| Centene Corp | 161.73bn | 3.07bn | 30.47bn | 67.70k | 10.47 | 1.13 | 7.09 | 0.1884 | 5.77 | 5.77 | 303.72 | 53.53 | 1.94 | -- | 9.57 | 2,388,863.00 | 3.66 | 2.58 | 6.39 | 3.99 | 10.37 | 11.59 | 1.89 | 1.37 | -- | 4.06 | 0.3911 | 0.00 | 6.54 | 20.70 | 124.79 | 24.59 | 3.43 | -- |
| Humana Inc | 115.01bn | 1.36bn | 35.61bn | 67.60k | 26.18 | 2.03 | 14.81 | 0.3096 | 11.29 | 11.29 | 948.23 | 145.88 | 2.17 | -- | -- | 1,701,331.00 | 2.72 | 7.57 | -- | -- | -- | -- | 1.25 | 3.35 | -- | 5.38 | 0.4249 | 12.54 | 14.54 | 13.33 | -11.30 | 7.65 | 10.41 | 13.25 |
| CVS Health Corp | 368.91bn | 5.02bn | 71.86bn | 300.00k | 14.51 | 0.9585 | 7.49 | 0.1948 | 3.94 | 3.94 | 290.60 | 59.57 | 1.46 | 17.78 | 36.33 | 1,229,707.00 | 1.99 | 3.03 | 2.97 | 4.20 | 14.20 | 17.07 | 1.36 | 2.30 | 0.5872 | 3.88 | 0.466 | 40.46 | 10.95 | 12.95 | 93.55 | -- | 8.27 | 3.89 |
| HCA Healthcare Inc | 69.62bn | 5.93bn | 84.16bn | 220.00k | 14.91 | -- | 8.35 | 1.21 | 22.28 | 22.28 | 261.95 | -8.57 | 1.22 | 5.54 | 7.29 | 316,459.10 | 11.98 | 11.99 | 16.88 | 15.75 | 84.85 | 84.10 | 9.81 | 10.17 | 0.9991 | 5.30 | 0.982 | 10.54 | 7.86 | 6.84 | -7.11 | 10.13 | 5.83 | 11.38 |
| Cigna Group | 232.59bn | 3.04bn | 91.81bn | 72.50k | 31.13 | 2.19 | 14.71 | 0.3947 | 10.60 | 10.60 | 811.50 | 150.61 | 1.51 | 43.48 | 9.91 | 3,208,083.00 | 2.18 | 4.09 | 3.30 | 5.55 | 11.21 | 13.98 | 1.44 | 3.61 | 0.7736 | 2.33 | 0.4368 | 13.69 | 8.17 | 32.15 | -22.97 | 14.42 | 24.40 | 161.81 |
| Elevance Health Inc | 174.02bn | 6.42bn | 93.60bn | 104.90k | 14.71 | 2.14 | 11.99 | 0.5379 | 27.44 | 27.44 | 743.42 | 188.74 | 1.53 | -- | -- | 1,658,866.00 | 5.63 | 6.03 | -- | -- | -- | -- | 3.67 | 3.96 | -- | 8.36 | 0.3822 | 20.18 | 9.42 | 13.21 | 1.58 | 9.97 | 1.42 | 14.56 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 20.31m | 8.76% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 11.58m | 4.99% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 10.69m | 4.61% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2024 | 9.78m | 4.22% |
| Geode Capital Management LLCas of 30 Sep 2024 | 4.85m | 2.09% |
| Sanders Capital LLCas of 30 Sep 2024 | 4.61m | 1.99% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 4.32m | 1.86% |
| Capital Research & Management Co. (International Investors)as of 30 Sep 2024 | 3.85m | 1.66% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 3.05m | 1.31% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2024 | 3.00m | 1.30% |
